Patent classifications
C
C12
C12Y
203/00
C12Y203/01
C12Y203/01006
C12Y203/01006
EXPRESSION SYSTEMS FOR THE ALPHA2ALPHA5BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF
Disclosed herein are isolated recombinant cells for the expression of 252 nicotinic acetylcholine receptor (nAChR) and methods of use thereof.
ALZHEIMER'S DISEASE GENE THERAPEUTICS AND METHODS OF USE THEREOF
The present disclosure provides recombinant vectors encoding a choline acetyltransferase (ChAT) polypeptide, compositions thereof, and methods of use thereof.